Similar articles for PMID: 29843367

Year	Number of Results
1997	1
2002	1
2003	2
2004	2
2005	3
2006	2
2007	2
2008	3
2009	2
2011	3
2012	3
2013	6
2014	11
2015	17
2016	20
2017	22
2018	16
2019	25
2020	30
2021	20
2022	6
2023	1
2024	0

1

Prognostic Value of RNASEH2A-, CDK1-, and CD151-Related Pathway Gene Profiling for Kidney Cancers.

Yang CA, Huang HY, Yen JC, Chang JG. Yang CA, et al. Int J Mol Sci. 2018 May 28;19(6):1586. doi: 10.3390/ijms19061586. Int J Mol Sci. 2018. PMID: 29843367 Free PMC article.

2

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.

Han G, Zhao W, Song X, Kwok-Shing Ng P, Karam JA, Jonasch E, Mills GB, Zhao Z, Ding Z, Jia P. Han G, et al. BMC Genomics. 2017 Oct 3;18(Suppl 6):678. doi: 10.1186/s12864-017-4026-6. BMC Genomics. 2017. PMID: 28984208 Free PMC article.

3

Identification of genes and pathways involved in kidney renal clear cell carcinoma.

Yang W, Yoshigoe K, Qin X, Liu JS, Yang JY, Niemierko A, Deng Y, Liu Y, Dunker A, Chen Z, Wang L, Xu D, Arabnia HR, Tong W, Yang M. Yang W, et al. BMC Bioinformatics. 2014;15 Suppl 17(Suppl 17):S2. doi: 10.1186/1471-2105-15-S17-S2. Epub 2014 Dec 16. BMC Bioinformatics. 2014. PMID: 25559354 Free PMC article.

4

Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.

He Z, Sun M, Ke Y, Lin R, Xiao Y, Zhou S, Zhao H, Wang Y, Zhou F, Zhou Y. He Z, et al. Oncotarget. 2017 Apr 25;8(17):27904-27914. doi: 10.18632/oncotarget.15842. Oncotarget. 2017. PMID: 28427189 Free PMC article.

5

PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.

Filipović J, Bosić M, Ćirović S, Životić M, Dunđerović D, Đorđević D, Živković-Perišić S, Lipkovski A, Marković-Lipkovski J. Filipović J, et al. Diagn Pathol. 2019 Oct 26;14(1):120. doi: 10.1186/s13000-019-0901-6. Diagn Pathol. 2019. PMID: 31655611 Free PMC article.

6

Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.

Wang Y, Yan K, Lin J, Wang J, Zheng Z, Li X, Hua Z, Bu Y, Shi J, Sun S, Li X, Liu Y, Bi J. Wang Y, et al. Aging (Albany NY). 2020 Nov 5;12(21):21854-21873. doi: 10.18632/aging.104001. Epub 2020 Nov 5. Aging (Albany NY). 2020. PMID: 33154194 Free PMC article.

7

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.

Nagao K, Shinohara N, Smit F, de Weijert M, Jannink S, Owada Y, Mulders P, Oosterwijk E, Matsuyama H. Nagao K, et al. BMC Cancer. 2018 Nov 15;18(1):1114. doi: 10.1186/s12885-018-5060-8. BMC Cancer. 2018. PMID: 30442117 Free PMC article.

8

Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.

Zhou L, Liu S, Li X, Yin M, Li S, Long H. Zhou L, et al. Mol Med Rep. 2019 May;19(5):3485-3496. doi: 10.3892/mmr.2019.10042. Epub 2019 Mar 15. Mol Med Rep. 2019. PMID: 30896867 Free PMC article.

9

Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.

Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD. Gong X, et al. Oncotarget. 2017 Mar 21;8(12):18657-18669. doi: 10.18632/oncotarget.15703. Oncotarget. 2017. PMID: 28423633 Free PMC article.

10

Influence of gene expression on survival of clear cell renal cell carcinoma.

Berglund A, Amankwah EK, Kim YC, Spiess PE, Sexton WJ, Manley B, Park HY, Wang L, Chahoud J, Chakrabarti R, Yeo CD, Luu HN, Pietro GD, Parker A, Park JY. Berglund A, et al. Cancer Med. 2020 Nov;9(22):8662-8675. doi: 10.1002/cam4.3475. Epub 2020 Sep 28. Cancer Med. 2020. PMID: 32986937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

181 results

Results by year